The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients With Bronchiectasis

Bronchiectasis and NTM Research Registry Investigators

doi:10.1016/j.chest.2021.02.019

The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients With Bronchiectasis

Bronchiectasis and NTM Research Registry Investigators

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	466-469
Number of pages	4
Journal	Chest
Volume	160
Issue number	2
DOIs	https://doi.org/10.1016/j.chest.2021.02.019
State	Published - Aug 2021

Access to Document

10.1016/j.chest.2021.02.019

Cite this

@article{b4b1ec827bc546e183a01c6c762b2338,

title = "The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients With Bronchiectasis",

author = "{Bronchiectasis and NTM Research Registry Investigators} and Metersky, {Mark L.} and Radmila Choate and Doreen Addrizzo-Harris and Aksamit, {Timothy R.} and Alan Barker and Ashwin Basavaraj and Daley, {Charles L.} and {Anne Daniels}, {M. Leigh} and Edward Eden and Angela DiMango and Kevin Fennelly and Johnson, {Margaret M.} and Knowles, {Michael R.} and Diego Maselli and McShane, {Pamela J.} and Edward Naureckas and Noone, {Peadar G.} and O'Donnell, {Anne E.} and Olivier, {Kenneth N.} and Julie Philley and Marcos Restrepo and Salathe, {Matthias A.} and Andreas Schmid and Byron Thomashow and Gregory Tino and Winthrop, {Kevin L.}",

note = "Funding Information: The BRR is a centralized database of patients with bronchiectasis entered at 16 sites throughout the United States sponsored and funded by the COPD Foundation, a 501(c)(3) nonprofit organization. Adult patients with a diagnosis of bronchiectasis confirmed by CT scan are eligible for inclusion. The Institutional Review Board (IRB) of each site approved the study, as did an administrative IRB for the data-collecting center (Western IRB, tracking number 20141341.) BRR methods have been previously reported. 4 Funding Information: FUNDING/SUPPORT: The authors acknowledge the COPD Foundation, a 501(c)(3) nonprofit organization, who manages the Bronchiectasis and NTM Research Registry. The Registry is funded by the Richard H. Scarborough Bronchiectasis Research Fund, the Anna-Maria and Stephen Kellen Foundation, and the Bronchiectasis and NTM Industry Advisory Committee. It should also be noted that this work would not have been possible without the comprehensive chart reviews and recording of data by the dedicated research coordinators and PIs at each of the participating Registry sites. The COPD Foundation had no role in the development of the research. ",

year = "2021",

month = aug,

doi = "10.1016/j.chest.2021.02.019",

language = "English",

volume = "160",

pages = "466--469",

journal = "Chest",

issn = "0012-3692",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients With Bronchiectasis

AU - Bronchiectasis and NTM Research Registry Investigators

AU - Metersky, Mark L.

AU - Choate, Radmila

AU - Addrizzo-Harris, Doreen

AU - Aksamit, Timothy R.

AU - Barker, Alan

AU - Basavaraj, Ashwin

AU - Daley, Charles L.

AU - Anne Daniels, M. Leigh

AU - Eden, Edward

AU - DiMango, Angela

AU - Fennelly, Kevin

AU - Johnson, Margaret M.

AU - Knowles, Michael R.

AU - Maselli, Diego

AU - McShane, Pamela J.

AU - Naureckas, Edward

AU - Noone, Peadar G.

AU - O'Donnell, Anne E.

AU - Olivier, Kenneth N.

AU - Philley, Julie

AU - Restrepo, Marcos

AU - Salathe, Matthias A.

AU - Schmid, Andreas

AU - Thomashow, Byron

AU - Tino, Gregory

AU - Winthrop, Kevin L.

N1 - Funding Information: The BRR is a centralized database of patients with bronchiectasis entered at 16 sites throughout the United States sponsored and funded by the COPD Foundation, a 501(c)(3) nonprofit organization. Adult patients with a diagnosis of bronchiectasis confirmed by CT scan are eligible for inclusion. The Institutional Review Board (IRB) of each site approved the study, as did an administrative IRB for the data-collecting center (Western IRB, tracking number 20141341.) BRR methods have been previously reported. 4 Funding Information: FUNDING/SUPPORT: The authors acknowledge the COPD Foundation, a 501(c)(3) nonprofit organization, who manages the Bronchiectasis and NTM Research Registry. The Registry is funded by the Richard H. Scarborough Bronchiectasis Research Fund, the Anna-Maria and Stephen Kellen Foundation, and the Bronchiectasis and NTM Industry Advisory Committee. It should also be noted that this work would not have been possible without the comprehensive chart reviews and recording of data by the dedicated research coordinators and PIs at each of the participating Registry sites. The COPD Foundation had no role in the development of the research.

PY - 2021/8

Y1 - 2021/8

UR - http://www.scopus.com/inward/record.url?scp=85111325427&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2021.02.019

DO - 10.1016/j.chest.2021.02.019

M3 - Article

C2 - 33617806

AN - SCOPUS:85111325427

SN - 0012-3692

VL - 160

SP - 466

EP - 469

JO - Chest

JF - Chest

IS - 2

ER -